Glycans in Diseases and Therapeutics

Glycomedicine functions a pivotal role in cell-cell adhesion i.e. a tool utilized by cells of the immune system through sugar-binding proteins called lectins, which identify specific carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play foremost roles in numerous biological phenomena as well as in various pathophysiological processes. Many researchers have now understood that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is a significant field of research and sometimes they require a glycobiology method to be exploited.

  • Genetic disorder of glycosylations
  • Glycoprotein ligand
  • Growth factors and oncogenes
  • Genetically engineered glycan

Related Conference of Glycans in Diseases and Therapeutics

October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany
March 17-18, 2019

World Congress on Genomics & Bioinformatics

Brisbane, Australia
March 18-19,2019

15th World Congress on

Structural Biology

Paris, France
May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
September 23-24, 2019

8th Glycobiology World Congress

Barcelona, Spain
September 23-24, 2019

8th Glycobiology World Congress

Barcelona, Spain
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in